Andreas Halvorsen’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.39M Hold
524,347
0.02% 89
2026
Q1
$4.7M Hold
524,347
0.01% 77
2025
Q4
$2.88M Hold
524,347
0.01% 76
2025
Q3
$2.09M Hold
524,347
0.01% 78
2025
Q2
$1.42M Hold
524,347
﹤0.01% 83
2025
Q1
$2.75M Hold
524,347
0.01% 89
2024
Q4
$4.03M Hold
524,347
0.01% 86
2024
Q3
$4.91M Hold
524,347
0.02% 83
2024
Q2
$5.62M Hold
524,347
0.02% 82
2024
Q1
$7.76M Hold
524,347
0.03% 82
2023
Q4
$10M Hold
524,347
0.04% 77
2023
Q3
$14.1M Hold
524,347
0.06% 75
2023
Q2
$23.7M Hold
524,347
0.1% 80
2023
Q1
$24M Hold
524,347
0.11% 73
2022
Q4
$27.6M Hold
524,347
0.14% 70
2022
Q3
$60.7M Hold
524,347
0.28% 66
2022
Q2
$31.7M Hold
524,347
0.14% 74
2022
Q1
$29.3M Hold
524,347
0.12% 81
2021
Q4
$40M Hold
524,347
0.12% 92
2021
Q3
$73.7M Buy
+524,347
New +$61.5M 0.2% 74

Other funds holding RLYB

Andreas Halvorsen's RLYB Position: Q2 2026 in Review

Andreas Halvorsen held its Rallybio (RLYB) position steady in Q2 2026 at 524,347 shares worth $8.39M. The position accounts for 0.02% of the portfolio, ranked #89.

Andreas Halvorsen first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $73.7M in Q3 2021. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Andreas Halvorsen held 524,347 shares of Rallybio worth $8.39M as of Q2 2026.
  • Andreas Halvorsen left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up 0.02% of Andreas Halvorsen's portfolio in Q2 2026, its #89 holding.
  • Andreas Halvorsen first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
  • Andreas Halvorsen's Rallybio position peaked at $73.7M in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.